News

Industrious and enthusiastic problem-solving scientist qualified by 6.5 years of biotech and post-doctoral experience in the biomedical field and drug development. Expertise in biochemistry, molecular biology, microbiology, cell culture, and complex carbohydrates. Project leader of small teams with responsibilities in the design, evaluation, production and purification of novel drug conjugates. Direct experience with customer support and transfer of processes to CMO. In addition, hands-on skills in small- to large-scale purification of proteins and polysaccharides, and development of analytical assays.

The Pharmaceutical Research and Manufacturers of America (PhRMA) has selected Oklahoma Medical Research Foundation physician-researcher Joan Merril as recipient of the 2016 Research & Hope Award for “Excellence in Academic/Government Research.”

At its annual meeting today in West Palm Beach, Fla., the Association of Independent Research Institutes presented the Oklahoma Medical Research Foundation’s Michael “Chip” Morgan with its highest honor.

OMRF will host a four-day research conference in Oklahoma City from Sept. 19 to 22. The meeting, titled “Biomarkers and Targeted Therapeutics in Sjögren’s (BATTS),” will focus on sharing and discussing the most recent advances and innovative strategies for improving the lives of patients with Sjögren’s syndrome.

This event offers employers a unique opportunity to promote internships and full-time positions exclusively to GCoE master’s and Ph.D. students. Because many career fairs are targeted toward students finishing undergraduate degrees, we created this event to ensure our graduate students meet companies seeking employees with advanced degrees.

In 1946, DNA was just a collection of letters. Genes were nicknames for those with the given name Eugene. And the first biotechnology company wouldn’t be born for another three decades. But in Oklahoma, a group of physicians and business leaders saw the potential that biomedical research held. This Sunday, Aug. 28, will mark the 70th anniversary of that moment.

First awarded in 2003, prior Center of Biomedical Research Excellence (COBRE) in Vascular Biology grants to OMRF have provided almost $23 million for recruiting and mentoring top-tier junior investigators and supporting their research with state-of-the-art core laboratory facilities.

The National Multiple Sclerosis Society has awarded OMRF scientist Robert Axtell, Ph.D., a two-year, $422,400 grant to study the interplay between two specific cell types that drive the activity and progression of multiple sclerosis.

OMRF scientist Kenneth Humphries, Ph.D., has been awarded a four-year, $1.72 million grant from the National Heart, Lung, and Blood Institute to investigate the effects of diabetes on the heart. The grant will allow Humphries to continue novel research about how a cellular switch called PKA, which controls how the heart contracts, is impaired by diabetes.

Peering into microscopes and venturing into the unknown, students from across the nation are wrapping up a summer of new discoveries at the Oklahoma Medical Research Foundation. Thirteen high school and college students were chosen for the Fleming Scholar Program, which allowed them eight weeks of hands-on biomedical research.